English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
  The AP-1 transcription factor Fra1 ihhibits follicular B cell differentiation into plasma cells

Grötsch, B., Brachs, S., Lang, C., Luther, J., Derer, A., Schlötzer-Schrehardt, U., et al. (2014). The AP-1 transcription factor Fra1 ihhibits follicular B cell differentiation into plasma cells. The Journal of Experimental Medicine, 211, 2199-2212.

Item is

Files

show Files

Locators

show

Creators

show
hide
 Creators:
Grötsch, Bettina, Author
Brachs, Sebastian, Author
Lang, Christine, Author
Luther, Julia, Author
Derer, Anja, Author
Schlötzer-Schrehardt, Ursula, Author
Bozec, Aline, Author
Fillatreau, Simon, Author
Berberich, Ingolf, Author
Hobeika, Elias1, Author           
Reth, Michael1, Author           
Wagner, Erwin F., Author
Schett, Georg, Author
Mielenz, Dirk, Author
David, Jean-Pierre, Author
Affiliations:
1Research Group and Chair of Molecular Immunology of the University of Freiburg, Max Planck Institute of Immunobiology and Epigenetics, Max Planck Society, ou_2243645              

Content

show
hide
Free keywords: -
 Abstract: The cornerstone of humoral immunity is the differentiation of B cells into antibody-secreting plasma cells. This process is tightly controlled by a regulatory gene network centered on the transcriptional repressor B lymphocyte-induced maturation protein 1 (Blimp1). Proliferation of activated B cells is required to foster Blimp1 expression but needs to be terminated to avoid overshooting immune reactions. Activator protein 1 (AP-1) transcription factors become quickly up-regulated upon B cell activation. We demonstrate that Fra1, a Fos member of AP-1, enhances activation-induced cell death upon induction in activated B cells. Moreover, mice with B cell-specific deletion of Fra1 show enhanced plasma cell differentiation and exacerbated antibody responses. In contrast, transgenic overexpression of Fra1 blocks plasma cell differentiation and immunoglobulin production, which cannot be rescued by Bcl2. On the molecular level, Fra1 represses Blimp1 expression and interferes with binding of the activating AP-1 member c-Fos to the Blimp1 promoter. Conversely, overexpression of c-Fos in Fra1 transgenic B cells releases Blimp1 repression. As Fra1 lacks transcriptional transactivation domains, we propose that Fra1 inhibits Blimp1 expression and negatively controls plasma cell differentiation through binding to the Blimp1 promoter. In summary, we demonstrate that Fra1 negatively controls plasma cell differentiation by repressing Blimp1 expression.

Details

show
hide
Language(s): eng - English
 Dates: 2014
 Publication Status: Issued
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Type: Peer
 Identifiers: eDoc: 701139
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: The Journal of Experimental Medicine
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: -
Pages: - Volume / Issue: 211 Sequence Number: - Start / End Page: 2199 - 2212 Identifier: -